Publications for Wilbert S. Aronow wilbert_aronow@nymc.edu
Aronow, W. S. (2015). Review of 2003 to 2015 guidelines on treatment of hypertension in patients with coronary artery disease. Journal of Hypertension and Management, 1(1), [Article 1]. This material can be found here.
Aronow, W. S. (2015). Thoracic aortic aneurysm. Angiology Open Access, 3, [Article e113]. doi:10.4172/2329-9495.1000e113
Aronow, W. S. (2015). Treating hypertension and prehypertension in older people: When, whom and how. Maturitas, 80(1), 31-36. doi:10.1016/j.maturitas.2014.10.001
Aronow, W. S. (2015). Treatment of cardiac hemochromatosis. Heart Research Open Journal, 2(3), e3-e5. doi:10.17140/HROJ-2-e002
Aronow, W. S. (2015). Treatment of hypertension in persons with coronary artery disease: What the guidelines recommend. Consultant, 55(10), 803-808. This material can be found here.
Aronow, W. S. (2015). Treatment of intermittent claudication due to peripheral arterial disease. Angiology Open Access, 3(1), [Article e111]. doi:10.4172/2329-9495.1000e111
Aronow, W. S. (2015). Treatment of lower extremity peripheral arterial disease. International Heart and Vascular Disease Journal, 3(5), 3-14. This material can be found here.
Aronow, W. S. (2015). Update on management of aneurysms of the abdominal aorta, its branch vessels, and the lower extremities. Angiology Open Access, 3(1), [Article e109]. doi:10.4172/2329-9495.1000e109
Aronow, W. S. (2015). What should the hemoglobin A1c level goal be in diabetics? International Journal of Diabetology & Vascular Disease Research, 3(10), 137-139. doi:10.19070/2328-353X-1500029
Aronow, W. S. (2015). White coat hypertension. Insights in Blood Pressure, 1(1), [Article 6]. This material can be found here.
Bajaj, N. S., Bhatia, V., Sanam, K., Ather, S., Hashim, T., Morgan, C., . . . Aronow, W. S. (2015). Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults. American Journal of Cardiology, 114(6), 909-913.
Banach, M., Aronow, W. S., Serban, C., Sahabkar, A., Rysz, J., . . . Voroneanu, L. (2015). Lipids, blood pressure and kidney update 2014. Pharmacological Research, 95-96, 111-125. doi:10.1016/j.phrs.2015.03.009
Banach, M., Aronow, W. S., Serban, M. C., Rysz, J., Voroneanu, L., & Covic, A. (2015). Lipids, blood pressure and kidney update 2015. Lipids in Health and Disease, 14(1), 167. doi:10.1186/s12944-015-0169-0
Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., . . . Aronow, W. S. (2015). Statin intolerance - an attempt at a unified definition. position paper from an International Lipid Expert Panel. Archives of Medical Science, 11(1), 1-23. doi:10.5114/aoms.2015.49807
Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., . . . Aronow, W. S. (2015). Statin intolerance-an attempt at a unified definition. position paper from an International Lipid Expert Panel. Expert Opinion on Drug Safety, 14(6), 935-955. doi:10.1517/14740338.2015.1039980
Bhatia, V., Bajaj, N. S., Sanam, K., Hashim, T., Morgan, C. J., Prabhu, S. D., . . . Aronow, W. S. (2015). Beta-blocker use and 30-day all-cause readmission in Medicare beneficiaries with systolic heart failure. The American Journal of Medicine, 128(7), 715-721. doi:10.1016/j.amjmed.2014.11.036
Chopra, R., Paul, L., Manickam, R., Aronow, W. S., & Maguire, G. P. (2015). Efficacy and adverse effects of drugs used to treat adult cystic fibrosis. Expert Opinion on Drug Safety, 14(3), 401-411. doi:10.1517/14740338.2015.994503
Garg, J., Aronow, W. S., Devabhaktuni, S., & Ahmad, H. (2015). Takotsubo syndrome (or apical ballooning syndrome) secondary to zolmitriptan. American Journal of Therapeutics, 22(2), e52-e56. doi:10.1097/01.mjt.0000433938.07244.05
Genarelli, M., & Aronow, W. S. (2015). Use of MKSAP 16 for American Board of Internal Medicine Examination. Archives of Medical Science, 11(6), 1354-1355. doi:10.5114/aoms.2015.56365
Gupta, T., Harikrishnan, P., Kolte, D., Khera, S., Aronow, W. S., Mujib, M., Palaniswamy, C., Sule, S., Jain, D., Lanier, G. M., Cooper, H. A., Frishman, W. H.,. . . & Panza, J. A. (2015). Outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy. The American Journal of Medicine, 128(8), 879-887.e1. doi:10.1016/j.amjmed.2015.02.025
Gupta, T., Harikrishnan, P., Kolte, D., Khera, S., Subramanian, K. S., Mujib, M., Palaniswamy, C., Sule, S., Jain, D., Lanier, G. M., Cooper, H. A., Frishman, W. H., Panza, J. A., . . . Aronow, W. S. (2015). Trends in management and outcomes of ST-elevation myocardial infarction in patients with end-stage renal disease in the United States. The American Journal of Cardiology, 115(8), 1033-1041. doi:10.1016/j.amjcard.2015.01.529
Gupta, T., Khera, S., Kolte, D., Aronow, W. S., & Iwai, S. (2015). Antiarrhythmic properties of ranolazine: A review of the current evidence. International Journal of Cardiology, 187, 66-74. doi:10.1016/j.ijcard.2015.03.324
Gupta, T., Khera, S., Kolte, D., Aronow, W. S., Fallon, J. T., Frishman, W. H., . . . Gass, A. (2015). Back from the brink: Catastrophic antiphospholipid syndrome. The American Journal of Medicine, 128(6), 574-577.
Gupta, T., Kolte, D., Harikrishnan, P., Khera, S.+, Aronow, W. S., Mujib, M., Palaniswamy, C., Sule, S., Jain, D., Cooper, H. A., Frishman, W. H., . . . Panza, J. A. (2015). Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention. Journal of the American Heart Association, 4(6), [Article e002069]. doi:10.1161/JAHA.115.002069
Harikrishnan, P., Palaniswamy, C., Kolte, D., Khera, S., Mujib, M., Aronow, W. S., Sule, S., Jain, D., Cooper, H. A., Jacobson, J., Iwai, S., Frishman, W. H., . . . Panza, J. A. (2015). Complete heart block complicating ST-segment elevation myocardial infarction temporal trends and association with in-hospital outcomes. JACC: Clinical Electrophysiology, 1(6), 529-538. doi:10.1016/j.jacep.2015.08.007
